Fate Therapeutics (FATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 1,027 | 1,027 | 1,026 | 1,027 | 1,322 |
| Gross Profit | 1,027 | 1,027 | 1,026 | 1,027 | 1,322 |
| Operating Expenses | 10,998 | 8,681 | 9,415 | 9,031 | 9,238 |
| Operating Income | -9,971 | -7,654 | -8,389 | -8,004 | -7,916 |
| Interest Expense | 266 | 329 | 385 | 435 | 488 |
| Other Income | 111 | 43 | 37 | 31 | 27 |
| Pre-tax Income | -10,126 | -7,940 | -8,737 | -8,408 | -8,377 |
| Net Income Continuous | -10,126 | -7,940 | -8,737 | -8,408 | -8,377 |
| Net Income | $-10,126 | $-7,940 | $-8,737 | $-8,408 | $-8,377 |
| EPS Basic Total Ops | -0.24 | -0.20 | -0.27 | -0.29 | -0.29 |
| EPS Basic Continuous Ops | -0.24 | -0.20 | -0.27 | -0.29 | -0.29 |
| EPS Diluted Total Ops | -0.24 | -0.20 | -0.27 | -0.29 | -0.29 |
| EPS Diluted Continuous Ops | -0.24 | -0.20 | -0.27 | -0.29 | -0.29 |
| EBITDA(a) | $-9,742 | $-7,410 | $-8,097 | $-7,671 | $-7,594 |